Search

Author/Creator Koch, Sven D.

1. 31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): part one: National Harbor, MD, USA. 9-13 November 2016. (16th November 2016)

Authors:
Lundqvist, Andreas; van Hoef, Vincent; Zhang, Xiaonan; Wennerberg, Erik; Lorent, Julie; Witt, Kristina; Sanz, Laia Masvidal; Liang, Shuo; Murray, Shannon; Larsson, Ola; Kiessling, Rolf; Mao, Yumeng; Sidhom, John-William; Bessell, Catherine A.; Havel, Jonathan; Schneck, Jonathan; Chan, Timothy A.;...
Journal:
Journal for immunotherapy of cancer
Issue:
Volume 4(2016)Supplement 1
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. 31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): part two: National Harbor, MD, USA. 9-13 November 2016. (16th November 2016)

Authors:
Ager, Casey; Reilley, Matthew; Nicholas, Courtney; Bartkowiak, Todd; Jaiswal, Ashvin; Curran, Michael; Albershardt, Tina C.; Bajaj, Anshika; Archer, Jacob F.; Reeves, Rebecca S.; Ngo, Lisa Y.; Berglund, Peter; ter Meulen, Jan; Denis, Caroline; Ghadially, Hormas; Arnoux, Thomas; Chanuc, Fabien; Fu...
Journal:
Journal for immunotherapy of cancer
Issue:
Volume 4(2016)Supplement 1
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. A large multicentre, randomized, double‐blind, cross‐over study in healthy volunteers to compare pharmacokinetics, pharmacodynamics and safety of a pegfilgrastim biosimilar with its US‐ and EU‐reference biologics. Issue 6 (21st February 2020)

Authors:
Bellon, Anne; Wang, Jessie; Skerjanec, Andrej; Velinova, Maria; Dickerson, Daniel; Sabet, Ahad; Ngo, Ly; O'Reilly, Terry; Tomek, Charles; Schussler, Steven; Schier‐Mumzhiu, Stefanie; Gattu, Sreekanth; Koch, Sven D.; Schelcher, Celine; Dobreva, Miryana; Boldea, Anca; Nakov, Roumen; Otto, Gordon P.
Journal:
British journal of clinical pharmacology
Issue:
Volume 86:Issue 6(2020)
Page Start:
1139
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. Distinct transcriptional changes in non-small cell lung cancer patients associated with multi-antigenic RNActive® CV9201 immunotherapy. (1st December 2016)

Authors:
Hong, Henoch S.; Koch, Sven D.; Scheel, Birgit; Gnad-Vogt, Ulrike; Schröder, Andreas; Kallen, Karl-Josef; Wiegand, Volker; Backert, Linus; Kohlbacher, Oliver; Hoerr, Ingmar; Fotin-Mleczek, Mariola; Billingsley, James M.
Journal:
Oncoimmunology
Issue:
Volume 5:Number 12(2016)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. Phase Ib evaluation of a self-adjuvanted protamine formulated mRNA-based active cancer immunotherapy, BI1361849 (CV9202), combined with local radiation treatment in patients with stage IV non-small cell lung cancer. Issue 1 (8th February 2019)

Authors:
Papachristofilou, Alexandros; Hipp, Madeleine M.; Klinkhardt, Ute; Früh, Martin; Sebastian, Martin; Weiss, Christian; Pless, Miklos; Cathomas, Richard; Hilbe, Wolfgang; Pall, Georg; Wehler, Thomas; Alt, Jürgen; Bischoff, Helge; Geißler, Michael; Griesinger, Frank; Kallen, Karl-Josef; Fotin-Mlecze...
Journal:
Journal for immunotherapy of cancer
Issue:
Volume 7:Issue 1(2019)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

7. Safety and immunogenicity of mRNA-LNP COVID-19 vaccine CVnCoV in Latin American adults: A phase 2 randomized study. (August 2022)

Authors:
Sáez-Llorens, Xavier; Lanata, Claudio; Aranguren, Elaine; Celis, Carlos R.; Cornejo, Rubelio; DeAntonio, Rodrigo; Ecker, Lucie; Garrido, Diegi; Gil, Ana I.; Gonzales, Marina; Hess-Holtz, Morgan; Leroux-Roels, Geert; Junker, Helga; Kays, Sarah-Katharina; Koch, Sven D.; Lazzaro, Sandra; Mann, Phili...
Journal:
Vaccine
Issue:
Volume 11(2022)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗